Date: 2013-04-22
Type of information: R&D agreement
Compound: undisclosed
Company: Evotec (Germany) Genentech, a member of Roche group (USA - Switzerland)
Therapeutic area: undisclosed
Type agreement: R&D
Action mechanism:
Disease: undisclosed
Details:
Financial terms:
Latest news: